Lataa...
Absolute bioavailability and safety of a novel rivastigmine nasal spray in healthy elderly individuals
AIMS: To test the feasibility of a novel rivastigmine nasal spray as prospective treatment for dementia. METHODS: A single dose, crossover absolute bioavailability and safety study was conducted with rivastigmine intravenous solution (1 mg) and nasal spray (3.126 mg) in eight healthy elderly individ...
Tallennettuna:
| Julkaisussa: | Br J Clin Pharmacol |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
John Wiley and Sons Inc.
2016
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5306491/ https://ncbi.nlm.nih.gov/pubmed/27639640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.13133 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|